Gland Pharma Limited
Leuprolide (3.75mg)
Hypolock LD 3.75mg Injection is used to treat prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.
Injection
Hypolock LD 3.75mg Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
No common side effects listed.
Caution is advised when consuming alcohol with Hypolock LD 3.75mg Injection. Please consult your doctor.
Information regarding the use of Hypolock LD 3.75mg Injection during breastfeeding is not available. Please consult your doctor.
Hypolock LD 3.75mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Hypolock LD 3.75mg Injection reduces the amount of sex hormones (testosterone in men and estrogen in women)..It works by decreasing the blood levels of testosterone in males..Hypolock LD 3.75mg Injection also acts by shutting off hormones made by the ovaries (female reproductive organs) so the estrogen (one of the hormones that causes females to have periods) level is lowered.
No, Hypolock LD 3.75mg Injection is not a chemotherapy medicine. It is a synthetic hormone analogue used to treat hormone-dependent conditions in men and women.
Yes, taking Hypolock LD 3.75mg Injection can cause periods to stop. In some cases, vaginal bleeding may occur. If you experience any unusual bleeding, please consult your doctor for guidance and follow their advice.
Yes, Hypolock LD 3.75mg Injection is a hormonal medicine that alters reproductive hormones in women. This medication is not recommended for use in pregnant women as it can harm the fetus and may lead to miscarriage.
Yes, using Hypolock LD 3.75mg Injection may decrease bone mineral density and weaken bones. Women should have their bone density assessed before starting treatment, especially if they are at increased risk of osteoporosis. Additional medications may be prescribed to prevent osteoporosis in patients with decreased bone mineral density.
Yes, Hypolock LD 3.75mg Injection can raise blood sugar levels and worsen glucose control in people with diabetes. It may also increase the risk of developing diabetes. Patients should monitor their blood glucose and glycosylated hemoglobin (HbA1c) regularly while taking this treatment.